The 20-minute In Discussion programs are biweekly updates on current topics in ADHD and feature news updates, an interview, and brief commentary.

In each program, Dr Robert Findling will discuss recent research, news, or breakthroughs in the field with the researchers involved to provide you with the latest knowledge in ADHD.

14/01 – High-dose atomoxetine treatment of ADHD

Correct dosing is important with any medicine, achieving the right balance between efficacy and side effects. Dr. Atilla Turgay of The Scarborough Hospital, Toronto, Ontario, Canada, studied a high-dose regimen of the non-stimulant atomoxetine to assess its effects and tolerability in children who responded poorly to the recommended standard dosing schedule for the drug.


11/12 – Is ADHD overdiagnosed?

According to the DSM-IV TR, approximately 3–7% of school-age children meet the criteria for a diagnosis of ADHD. However, it is commonly believed, possibly due to the influence of the media, that ADHD is actually overdiagnosed. Dr. Mark J. Sciutto of Muhlenberg College in Allentown, Pennsylvania, investigated the matter and discusses his findings.


26/09 – ADHD service use patterns in youth

Dr. Mark Wolraich, of the University of Oklahoma Health Sciences Center discusses his work reviewing how youths with ADHD utilize the primary care, mental health, and educational service system sectors, and what barriers there are to productive, coordinated care for these youngsters.


12/09 – Brain morphology and ADHD

Does ADHD – or the treatment of ADHD – cause changes in brain morphology? Brain imaging studies have been performed to examine this question, looking at treatment-naïve children with ADHD, children with a history of stimulant treatment, and healthy controls. Dr. Steven Pliszka of the University of Texas Health Science Center tells us what these studies have found.


22/08 – Health problems and quality of life in children with ADHD

Just how much does ADHD impact on a child’s life? Dr. Anne Riley of the Johns Hopkins University Bloomberg School of Public Health joins us to talk about her Child Health and Illness Profile rating scale which she has used to investigate health-related quality of life in children with ADHD in Europe.


08/08 – Cognitive-behavioral approaches to ADHD treatment in adulthood

Although ADHD treatments are generally effective, many individuals treated with medications continue to experience some residual symptoms and functional impairments. These may be improved by the use of a structured, cognitive-behavioral treatment approach, and Dr. Steven Safren, Director of the Behavioral Medicine Service at Massachusetts General Hospital and associate professor at Harvard Medical School, discusses the options available and their benefits in adult ADHD.


25/07 – ADHD in primary care

With the identification and treatment of ADHD being increasingly based in the primary care office, where children must also be monitored for comorbid disorders and referred for additional help when necessary, it is imperative for primary care physicians to have knowledge and access to support about the condition. Dr. Alison Schonwald of the Children's Hospital, Boston, USA, joins us to discuss the current status of ADHD in the primary care office.


11/07 – ADHD and achievement

Do ADHD and its associated effects on achievement dissipate as individuals get older? Dr. Thomas Frazier of the Cleveland Clinic Foundation reports the findings of his meta-analysis which aimed to answer this question and quantify these effects of ADHD across the lifespan.


27/06 – ADHD and comorbid anxiety

Research has suggested that anxiety in ADHD may partially inhibit impulsivity, make working memory deficits worse, and may be qualitatively different from other anxiety conditions. Dr. Anthony Rostain of the University of Pennsylvania discusses the etiology and effects of anxiety comorbid with ADHD.